There is a need for effective non-surgical treatment options in patients with non-muscle invasive bladder cancer (NMIBC) in whom Bacillus Calmette-Guerin (BCG) therapy has failed. We aimed to determine the efficacy of Electromotive Drug Administration (EMDA) of mitomycin C (MMC) in BCG unresponsive patients.

MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE / Juvet*, Tristan; Wallis, Christopher; Krimus, Lior; Kuk, Cynthia; Erlich, Annette; Mari, Andrea; Kulkarni, Girish; Fleshner, Neil; Zlotta, Alexandre. - In: THE JOURNAL OF UROLOGY. - ISSN 0022-5347. - ELETTRONICO. - 203:(2020), pp. e1121-e1121. [10.1097/JU.0000000000000959.01]

MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

Mari, Andrea;
2020

Abstract

There is a need for effective non-surgical treatment options in patients with non-muscle invasive bladder cancer (NMIBC) in whom Bacillus Calmette-Guerin (BCG) therapy has failed. We aimed to determine the efficacy of Electromotive Drug Administration (EMDA) of mitomycin C (MMC) in BCG unresponsive patients.
2020
Juvet*, Tristan; Wallis, Christopher; Krimus, Lior; Kuk, Cynthia; Erlich, Annette; Mari, Andrea; Kulkarni, Girish; Fleshner, Neil; Zlotta, Alexandre...espandi
File in questo prodotto:
File Dimensione Formato  
JU.0000000000000959.01.pdf

Accesso chiuso

Descrizione: Articolo principale
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 43.17 kB
Formato Adobe PDF
43.17 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1195555
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact